An Integrated Program for the Treatment of First Episode of Psychosis

NCT01321177 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 404

Last updated 2021-10-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine how services should be provided to reduce symptoms and improve life functioning for adolescents and adults who have been recently diagnosed with schizophrenia.

Conditions

  • Schizophrenia
  • Schizoaffective Disorder
  • Schizophreniform Disorder
  • Brief Psychotic Disorder
  • Psychotic Disorder NOS

Interventions

BEHAVIORAL

Integrated Treatment

Integrated program of treatments and services delivered by a coordinated team of providers that includes: * education about schizophrenia and its treatment for the participants and their family members * medication for symptoms and preventing relapse that uses a computerized decision support system * strategies for managing the illness and building personal resilience * help getting back to school or work using a supported employment/education model

BEHAVIORAL

Community Care

Standard mental health treatments and services offered at the local agency that may include : * medication for symptoms and preventing relapse * psychosocial therapy which may include a range of behavioral treatments and supportive services * Case management

Sponsors & Collaborators

  • State University of New York - Downstate Medical Center

    collaborator OTHER
  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • University of California, Los Angeles

    collaborator OTHER
  • Dartmouth-Hitchcock Medical Center

    collaborator OTHER
  • Research Foundation for Mental Hygiene, Inc.

    collaborator OTHER
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • Northwell Health

    lead OTHER

Principal Investigators

  • John Kane, MD · Feinstein Institute for Medical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2014-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321177 on ClinicalTrials.gov